Paydirt
AD
Insider

Atul Dandekar

CSBO

Atul Dandekar (CSBO) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $2.9M of MAZE (72,400 sh across 2 lots, as filed), executed Dec 29 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.8M
shares × price, as filed
Last traded
Aug 28
Filed Aug 31

Median ADV $16.9M across their filed names

Open performance
Volume by month
$2.9M$1.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2025 · sells $2.9MFeb 2026 · sells $280KMar 2026 · sells $341KApr 2026 · sells $196KMay 2026 · sells $190KJun 2026 · sells $198KJul 2026 · sells $404KAug 2026 · sells $207K
Buys $0 Sells $4.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names
MAZE Maze Therapeutics, Inc. MAZE · 0 buys · 9 sells 9 filings
Recent filings
MAZESALE Maze Therapeutics, Inc. View filing → $2.9M
72,400 sh across 2 lots
Exec Dec 29 2025
Filed Dec 31 2025 · 5:30 PM ET